Alkeon Capital Management
TGTX icon

Alkeon Capital Management’s TG Therapeutics TGTX Stock Holding History

Alkeon Capital Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,547,875
Closed -$38.4M – 115
2023
Q2 		$38.4M Sell
1,547,875
-1,142,048
-42% -$29.5M 0.07% 84
2023
Q1 		$40.5M Sell
2,689,923
-354,494
-12% -$5.38M 0.09% 85
2022
Q4 		$36M Buy
3,044,417
+1,401,742
+85% +$10.2M 0.14% 91
2022
Q3 		$9.72M Sell
1,642,675
-124,455
-7% -$816K 0.03% 121
2022
Q2 		$7.51M Sell
1,767,130
-30,880
-2% -$193K 0.02% 129
2022
Q1 		$17.1M Sell
1,798,010
-70,291
-4% -$814K 0.03% 126
2021
Q4 		$35.5M Sell
1,868,301
-2,200,000
-54% -$57.1M 0.07% 115
2021
Q3 		$135M Sell
4,068,301
-14,194
-0.3% -$439K 0.23% 87
2021
Q2 		$158M Sell
4,082,495
-8,196
-0.2% -$322K 0.23% 80
2021
Q1 		$197M Buy
4,090,691
+12,533
+0.3% +$602K 0.29% 68
2020
Q4 		$212M Buy
4,078,158
+1,303,158
+47% +$44M 0.35% 58
2020
Q3 		$74.3M Buy
2,775,000
+510,000
+23% +$11.7M 0.14% 92
2020
Q2 		$44.1M Buy
2,265,000
+700,000
+45% +$11.3M 0.11% 100
2020
Q1 		$15.4M Buy
1,565,000
+565,000
+57% +$7.14M 0.07% 113
2019
Q4 		$11.1M Buy
+1,000,000
New +$7.6M 0.04% 107

Other funds holding TGTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Alkeon Capital Management's TGTX Position: Q3 2023 in Review

Alkeon Capital Management sold out of TG Therapeutics (TGTX) in Q3 2023, closing a stake of 1,547,875 shares — an estimated $38.4M sold.

Alkeon Capital Management first reported a position in TGTX in Q4 2019 and held it in 15 quarters. The position peaked at $212M in Q4 2020. 236 funds tracked by Wall St. Rank hold TGTX as of Q3 2023.

  • Alkeon Capital Management reported no remaining TG Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Alkeon Capital Management sold 1,547,875 TG Therapeutics shares in Q3 2023, an estimated $38.4M.
  • Alkeon Capital Management first reported a position in TG Therapeutics in Q4 2019 and held it in 15 quarters.
  • Alkeon Capital Management's TG Therapeutics position peaked at $212M in Q4 2020.
  • 236 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2023.

Based on Alkeon Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.